Status:
TERMINATED
Gait and Functional Improvement in Total Knee Arthroplasty With the Use of Verasense for Soft Tissue Balancing
Lead Sponsor:
Orthosensor, Inc.
Conditions:
Osteoarthritis
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
The primary objectives of this study are to understand the effects of soft-tissue balancing on Gait, function and rehabilitation potential after sensor-assisted Total Knee Arthroplasty and correlate I...
Eligibility Criteria
Inclusion
- Subject must be a candidate for a primary PCL retaining total knee arthroplasty
- Subject must be diagnosed with one or more of the following conditions: osteoarthritis, avascular necrosis, rheumatoid or other inflammatory arthritis, post-traumatic arthritis
- Subject is between the age of 45 - 80 years
- Subject is likely to be available for all study visits
- Subject is able and willing to sign the informed consent and follow study procedures
Exclusion
- Prior total knee arthroplasty, ligament insufficiencies, prior surgeries such as ACL or PCL reconstructions, posterolateral reconstructions, osteotomies, tibia plateau fractures
- Range of Motion less than 90 degrees, flexion contracture of more than 20 degrees
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 12 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02290119
Start Date
April 1 2018
End Date
October 12 2022
Last Update
February 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sinai Hospital of Baltimore - Rubin Institute of Advanced Orthopedics Center for Joint Preservation and Reconstruction
Baltimore, Maryland, United States, 21215-5271